Cargando…
Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis
Persistent breathlessness >28 days after acute COVID-19 infection has been identified as a highly debilitating post-COVID symptom. However, the prevalence, risk factors, mechanisms and treatments for post-COVID breathlessness remain poorly understood. We systematically searched PubMed and Embase...
Autores principales: | Zheng, Bang, Daines, Luke, Han, Qing, Hurst, John R., Pfeffer, Paul, Shankar-Hari, Manu, Elneima, Omer, Walker, Samantha, Brown, Jeremy S., Siddiqui, Salman, Quint, Jennifer K., Brightling, Christopher E., Evans, Rachael A., Wain, Louise V., Heaney, Liam G., Sheikh, Aziz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724798/ https://www.ncbi.nlm.nih.gov/pubmed/36323418 http://dx.doi.org/10.1183/16000617.0071-2022 |
Ejemplares similares
-
Characteristics and risk factors for post-COVID-19 breathlessness after hospitalisation for COVID-19
por: Daines, Luke, et al.
Publicado: (2023) -
The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease
por: Adeloye, Davies, et al.
Publicado: (2021) -
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls
por: Zheng, Bang, et al.
Publicado: (2023) -
Use of the ReCIVA device in breath sampling of patients with acute breathlessness: a feasibility study
por: Holden, Karl A., et al.
Publicado: (2020) -
Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms
por: Han, Qing, et al.
Publicado: (2022)